Design and Development of Phytoconstituent Based Nanoformulations for Targeted Anti-Cancer Therapy Using Molecular Docking Approaches
1
Associate Professor, Dr. Rajendra Gode Institute of Pharmacy, University Mardi Road, Amravati 444602
2
Professor, Department of Biotechnology, SR Institute of Management & Technology, Lucknow, U. P 226201
3
Principal & Associate Professor, Kazi Nazrul Islam Pharmaceutical Sciences, Ghatal, West Medinipur, West Bengal 721222
4
Professor & HoD, Faculty of Pharmaceutical Science, Assam down town University, Sankar Madhab Path, Gandhi Nagar, Panikhaiti, Guwahati, Assam, India, 781026
5
Faculty of Pharmaceutical Science, Assam down town University, Sankar Madhab Path, Gandhi Nagar, Panikhaiti, Guwahati, Assam, India, 781026
6
Assistant Professor, Sir C.R Reddy College of Pharmaceutical Sciences, Eluru, Kukatpally, Hyderabad 500072
7
Assistant Professor, University of Science and Technology Meghalaya, Kiling Road, Baridua, 9th Mile, Ri-Bhoi, Meghalaya 793101
8
Associate Professor, Vishwakarma University School of Pharmacy Pune, Maharashtra 411048 India
Received: 2025-10-02
Revised: 2025-10-31
Accepted: 2025-11-08
Published: 2025-11-16
Cancer remains one of the leading causes of mortality worldwide, with conventional therapies often hindered by systemic toxicity, multidrug resistance, and limited selectivity towards tumour cells. The integration of phytoconstituents—bioactive compounds derived from medicinal plants—with nanotechnology offers a promising strategy to overcome these limitations. This study focuses on the design and development of phytoconstituent-based nanoformulations tailored for targeted anti-cancer therapy, guided by molecular docking approaches to optimize drug-target interactions. Nanoformulations such as liposomes, polymeric nanoparticles, dendrimers, and micelles provide controlled release, enhanced bioavailability, and selective tumor accumulation. Molecular docking aids in predicting and analysing the binding efficiency of selected phytoconstituents with cancer-associated proteins, thereby ensuring rational formulation design. Results highlight the synergistic potential of computational and formulation sciences, setting a path for effective and safer therapeutic interventions.
Phytoconstituents, Nanoformulations, Cancer Therapy, Molecular Docking, Targeted Drug Delivery.